Talimogene laherparepvec can initiate plasma cell invasion into infiltrated melanoma lesions – a case series
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16922
Abstract: Talimogene laherparepvec (T-VEC) is a genetically engineered herpes simplex virus type 1 (HSV-1) and used in locally advanced melanoma patients. Its mode of action is not fully understood. We present three cases where T-VEC caused… read more here.
Keywords: laherparepvec initiate; talimogene laherparepvec; plasma cell; initiate plasma ... See more keywords